PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
21-Apr-2022 Evaluate announces global strategic collaboration with Treehill Partners Evaluate
21-Apr-2022 Genovac Acquires the Carterra LSA® Instrument to Enable State-of-the-Art Antibody Screening and Characterization Services Genovac
21-Apr-2022 Biocomposites wins two Queen's Awards for Enterprise in Innovation and International Trade Biocomposites
21-Apr-2022 EIB provides €15 million to fund coronavirus research at IRBM IRBM SpA
21-Apr-2022 Addressing age-related challenges of pharmaceutical care University of Strathclyde
21-Apr-2022 PacBio transforms access to the epigenome and streamlines workflows PacBio
21-Apr-2022 Tackling Health Disparities and Inequities for Women with Heart Failure: New Program Encourages Black and Latina Women to Demand More From Their Care Lilly
21-Apr-2022 Merck Announces That Joseph Romanelli Will Lead Merck Human Health International, Effective August 1, 2022 Merck
21-Apr-2022 Syneos Health Promotes Baba Shetty to President, Technology and Data Solutions, and Suma Ramadas to Executive Vice President, Medical Affairs Syneos Health
21-Apr-2022 MPH Health Care AG: Preliminary IFRS result 2021 MPH Health Care AG
21-Apr-2022 Xlife Sciences: Date of publication Annual Report 2022 Xlife Sciences AG
21-Apr-2022 Kuros Biosciences’s MagnetOs Flex Matrix Cleared by FDA for Spinal Indications Kuros Biosciences AG
21-Apr-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Report Full Year 2021 Financial Results and Operational Progress on April 28, 2022 Vivoryon Therapeutics N.V.
20-Apr-2022 SynBiotic SE and Enchilada Group: Joint venture to launch first cannabis store in Germany SynBiotic SE
20-Apr-2022 Pharmaceutical Manufacturing And Packaging Congress 2022 Connects Pharma Leaders PHARMAP 2022
20-Apr-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Participate at Upcoming Investor Conferences Vivoryon Therapeutics N.V.
20-Apr-2022 Leading inhalation APIs expert Inke to triple production capacity Inke
20-Apr-2022 Kite Receives U.S. FDA Approval of New State-of-the-Art CAR T-Cell Therapy Manufacturing Facility in Maryland Kite
20-Apr-2022 Regeneron to Acquire Checkmate Pharmaceuticals and its Investigational Immune Activator for Potential use in Multiple Tumor Types Regeneron
20-Apr-2022 atai Life Sciences to Participate in Upcoming April Investor Conference atai Life Sciences